What is it about?
This clinical trial demonstrates for the first time the efficacy of reconsolidation blockade for posttraumatic stress disorder, a novel therapeutic procedure which consists of thiking -once a week for six consecutive weeks- about one's trauma under the influence of the beta-blocker propranolol.
Featured Image
Read the Original
This page is a summary of: Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial, American Journal of Psychiatry, May 2018, American Psychiatric Association,
DOI: 10.1176/appi.ajp.2017.17050481.
You can read the full text:
Contributors
The following have contributed to this page